PSMD1 and neoplasm: Terashima et al. evaluated the tumor gene expression profiles of 102 patients who received adjuvant chemotherapies via a DNA microarray and found that the cluster of differentially expressed genes that favored S-1 was enriched with immune-related genes [38].